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Post-transcriptional regulation of cellular mRNA is essential for protein synthesis. Here we
describe the importance of mRNA translational repression and mRNA subcellular location for
protein expression during B lymphocyte activation and the DNA damage response. Cyto-
plasmic RNA granules are formed upon cell activation with mitogens, including stress
granules that contain the RNA binding protein Tia1. Tia1 binds to a subset of transcripts
involved in cell stress, including p53 mRNA, and controls translational silencing and RNA
granule localization. DNA damage promotes mRNA relocation and translation in part due to
dissociation of Tia1 from its mRNA targets. Upon DNA damage, p53 mRNA is released from
stress granules and associates with polyribosomes to increase protein synthesis in a CAP-
independent manner. Global analysis of cellular mRNA abundance and translation indicates
that this is an extended ATM-dependent mechanism to increase protein expression of key
modulators of the DNA damage response.
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Programmed DNA damage occurs during B-cell develop-ment to generate highly diverse immunoglobulins (Ig). Inpro- and pre-B cells, the formation of double strand DNA
breaks (DSB) is required for recombination of the variable (V),
joining (J), and diversity (D) gene segments of the Ig loci (VDJ
recombination) to generate a functional B cell receptor (BCR)1.
Cytosine deamination by activation-induced cytidine deaminase
(AID) in mature B cells allows class switch recombination (CSR)
and somatic hypermutation (SHM), two mechanisms that
increase the antibody repertoire upon antigen encounter2–4. B
lymphocytes rely on constant monitoring of genome integrity.
DNA damage repair (DDR) pathways, including homologous
recombination (HR), non-homologous end joining (NHEJ), base
excision repair (BER) and mismatch-mediated repair (MMR), are
ﬁnely coupled to cell cycle progression5, differentiation6 and
apoptosis upon B-cell activation to prevent B cell tumour trans-
formation7. Cell cycle checkpoints are essential for timely DNA
repair. ATM and p53 activation enforce both G1 and G2 cell cycle
arrest and activation of DDR pathways8, 9. ATM−/− and p53−/− B
cells show defects in VDJ and class-switch recombination10–12.
Notably, mice deﬁcient in p53 and NHEJ or H2A.X develop
aggressive B-cell lymphomas13–15. Lack of VDJ and class-switch
recombination in the absence of NHEJ repair is not rescued by
p53 deﬁciency13, which highlights the role of p53-mediated
apoptosis in preventing the survival and expansion of tumour-
transformed B lymphocytes.
P53 expression and activity is regulated both at the level of
mRNA and protein16–18. It has been proposed that Bcl6 inhibi-
tion of p53 transcription is required for promoting
error-prone DNA repair in germinal center (GC) B cells under-
going clonal expansion, CSR and SHM without inducing an
apoptotic response19. However, recent characterization of the
transcriptomes of follicular and GC B cells by deep sequencing
indicates that p53 mRNA abundance does not change
substantially20, 21, suggesting that other mechanisms in addition
to transcription are important for p53 expression in B lympho-
cytes. Here we describe a general post-transcriptional mechanism
that uncouples mRNA expression and protein synthesis upon B-
cell activation. p53 protein is hardly detected in activated B
lymphocytes, at least in part due to localization of its mRNA
within cytoplasmic RNA granules where translation into protein
is inhibited.
Cytoplasmic RNA granules are key modulators of
post-transcriptional gene expression22. They are microscopically
visible aggregates of ribonucleoprotein (RNP) complexes often
formed upon stress-induced translational silencing. Disassembly
of polyribosomes from messenger RNA can drive the formation
of two RNA granule types in mammalian cells with distinct
protein composition and functions: processing bodies (PBs)
contain components of the mRNA decay machinery23, 24; and
stress granules (SGs) contain members of the translational
initiation complex25, 26 and several translational silencers,
including Tia1 and Tia-like 1 (Tial1), that contribute to polysome
disassembly and mRNA translational arrest. Although stress-
induced PBs and SGs have been extensively studied in model cell
systems, very little is known about whether they are formed and
functional in primary cells. Here, we present evidence that for-
mation of RNA granules controls post-transcriptional gene
expression upon B cell activation. Exchange of mRNA transcripts
between SGs and polysomes allows rapid translation of key
modulators of the DNA damage response.
The RNA-binding protein Tia1 has an important role in SG
nucleation. Tia1 overexpression induces the assembly of SGs in
the absence of stress25, whereas depletion of the glutamine-rich
prion-related domain of Tia1 impairs SGs formation27. Tia1 and
Tial1 are essential for cell development and differentiation28, 29.
Tial1 knockout (KO) mice are embryonic lethal, whereas 50% of
Tia1-KO mice die by 3 weeks of age. Tia1-KO mouse survivors
have profound immunological defects associated with increased
production of TNF and IL-629. By using individual-nucleotide
resolution UV crosslinking and immunoprecipitation (iCLIP)30
and nucleus-depleted cell extracts we have identiﬁed the mRNA
targets of Tia1 in activated B lymphocytes. Tia1 protein accu-
mulates in SGs and is associated with translationally silenced
mRNAs including that encoding the transcription factor p53.
Genome-wide analysis of mRNA abundance and translation
highlights the importance of mRNA subcellular location and
translational repression for B-cell activation and clonal expan-
sion. DNA damage induces Tia1 dissociation from its mRNA
targets and translocation of these mRNAs out of SGs. This
enables rapid protein synthesis of key transcription factors for cell
cycle arrest, DNA damage repair and apoptosis.
Results
RNA granules are assembled upon B-cell activation. Upon
activation with antigens, resting B lymphocytes become meta-
bolically active and initiate a genetic program for cell growth,
division and differentiation. Analysis by RT-qPCR showed that
the abundance of transcripts encoding protein components of SG
and PB increased after cell treatment with the mitogens LPS and
antiCD40 + IL4 + IL5 (Fig. 1a and Supplementary Fig. 1A) indi-
cating that post-transcriptional control of mRNA processing and
storage might increase upon B-cell activation. Indeed, protein
expression of Dcp1a and Tia1, two speciﬁc markers for PB and
SG, respectively, was increased in B cells stimulated with mito-
gens (Fig. 1b and Supplementary Fig. 1B). PBs and SGs were rare
in ex vivo isolated B cells but accumulated upon B-cell activation
(Fig. 1c, Supplementary Fig. 1C, D). Co-staining of Dcp1a and
Tia1 in activated B cells (Supplementary Fig. 1E) suggested that
PBs and SGs were discrete entities, although they could be found
located proximally to each other (Supplementary Fig. 1E) as
previously seen in non-lymphoid cells31. The eukaryotic initiation
factor eIF3η co-localized with Tia1 (Supplementary Fig. 1F)
indicating that translation initiation factors accumulate in SGs as
previously shown26.
In order to identify candidate mRNA transcripts that could be
silenced within SGs, we performed iCLIP for Tia1 using
cytoplasmic extracts of activated B lymphocytes (Fig. 1d and
Supplementary Fig. 2A). Analysis of genomic mappability of the
cDNAs uniquely identiﬁed by iCLIP showed that Tia1 preferen-
tially binds to U-rich elements in the 3′UTR of mature transcripts
(Supplementary Fig. 2B, C). Fewer than 5% of the reads were
mapped to introns (Fig. 1d and Supplementary Fig. 2C). This
result suggested that depletion of the cell nucleus was highly
efﬁcient. Peak enrichment analysis identiﬁed mRNA transcripts
of 3888 genes whose 3′UTR was targeted by Tia1 in the two
independent experiments performed (Fig. 1e and Supplementary
Data 1). Gene set enrichment analysis showed that Tia1 binds
RNAs associated with the signalling and metabolic switch
occurring upon B-cell activation and genes regulating cell growth
and apoptosis (Fig. 1f and Supplementary Fig. 2D). Although it is
possible that not all transcripts bound by Tia1 will be located in
SGs, we hypothesized that they are likely to be under post-
transcriptional silencing to a certain extent as Tia1 and other SG-
components like G3BP1 are not associated with ribosomes in B
cells (Supplementary Fig. 3), which is consistent with previous
reports26, 32.
DNA damage induces global changes in mRNA translation.
AID expression upon B-cell activation induces DNA double
strand breaks and triggers CSR and SHM2, 6. To evaluate global
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mRNA translation in activated B cells undergoing a DNA damage
response we used etoposide, a topoisomerase II inhibitor that
induces DNA double-strand breaks. Using sucrose gradients, we
separated mature mRNA transcripts into 13 fractions based on
their ribosomal density. Quantitation of mRNA transcripts within
monosomes, light polysomes and heavy polysomes was
performed by 3′end RNA sequencing (3′ RNA-seq). Cellular
mRNA abundance was quantiﬁed by mRNAseq (Supplementary
Data 2). Integration of the results from both methodologies
allowed us to identify global changes in mRNA abundance,
mRNA association with ribosomes (hereafter referred to as
ribosome association) and mRNA distribution along polysome
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fractions (hereafter referred to as polysome distribution; Fig. 2a).
Cellular mRNA abundance of transcripts encoded by 6340 genes
(Ensembl gene annotation) changed upon induction of DNA
damage with etoposide (Fig. 2b and Supplementary Data 2).
Although etoposide globally reduced polysome assembly in B
cells (Supplementary Fig. 3A), 53% of these genes (3355 out of
6340 genes) showed no signiﬁcant changes in the amount of
mRNA associated with ribosomes or their distribution along
polysomes (Fig. 2b, black dots), suggesting that changes in mRNA
abundance are not always linked to changes in translation.
A total of 3580 genes were differentially translated upon DNA
damage induction (Fig. 2b and Supplementary Data 3), with
changes in the polysome distribution mostly associated with
changes in the monosome and heavy fractions (Fig. 2c and
Supplementary Data 3, 4). 83% of these genes (2985 out of 3580
genes) were differentially expressed, linking their cellular mRNA
abundance with translation (Fig. 2b). In all, 595 genes showed
signiﬁcant changes in ribosome association but not in cellular
mRNA abundance, indicating a prominent role for translational
control (Fig. 2b, red dots). Differential ribosome association
highly correlated with changes in polysome distribution (Fig. 2d,
e). Twenty percent of the 3355 differentially expressed genes that
showed no changes in the amount of RNA associated with
ribosomes, showed a change in polysome distribution as
measured by a signiﬁcant change in mRNA abundance in any
one of the 13 polysome fractions. By contrast, over 50% of the
3580 genes that showed global changes in ribosome association
showed signiﬁcant changes in the amount of mRNA in at least
one of these fractions in our polysome distribution analysis
(Fig. 2d). Analysis of signiﬁcant changes in mRNA abundance in
monosome, light and heavy polysome fractions showed that
mRNAs with differential mRNA expression and ribosome
association were mostly found in the heavy polysome fractions
(Fig. 2d). Similarly, over 60% of mRNAs that showed changes in
polysome distribution were differentially expressed or associated
with ribosomes (Fig. 2e). Less than 10% of mRNAs showed
changes in “Riboload”, a measure of mRNA distribution in heavy
polysomes that is independent of any changes in mRNA
abundance (Fig. 2e). This suggests that changes in polysome
distribution caused by etoposide are linked to both changes in
mRNA abundance and/or ribosome association. These propor-
tions did not change if mRNAs were classiﬁed based on changes
in their abundance in the monosome, light or heavy polysome
fractions (Fig. 2e). Taken together, these results show that a
signiﬁcant fraction of genes in B cells are subject to post-
transcriptional regulation of mRNA translation following DNA
damage.
Tia1 regulates mRNA translation upon etoposide treatment.
Tia1 mRNA targets in B cells were highly responsive to DNA
damage. Total mRNA abundance and/or the amount of mRNA
associated with ribosomes changed for 77% of Tia1 mRNA tar-
gets following treatment with etoposide (Fig. 3a). The greater the
number of unique iCLIP cDNAs mapped to a given Tia1 mRNA
target the greater the likelihood for changes in mRNA polysome
distribution (Fig. 3b). Abundance and translation of most Tia1
mRNA targets was reduced after DNA damage induction
(Fig. 3c). These were genes related to B-cell metabolism and
proliferation (Fig. 3d and Supplementary Data 5) and they
resembled the overall reduction in mRNA abundance and
translation of highly expressed genes (Fig. 4a, b).
Notably, the translation of 20% of Tia1- mRNA targets was
increased upon etoposide treatment including those related to the
cell stress response (Fig. 3c, d and Supplementary Data 5).
Analysis of mRNA distribution along heavy polysomes indicated
that changes in mRNA translation were largely linked to
differential mRNA abundance, independently of whether they
were targets of Tia1 (Fig. 4c). Among the 5% of Tia1 mRNA
targets with differential mRNA translation, but no changes in
cellular mRNA abundance, we identiﬁed mRNAs encoding two of
the key transcription factors that control the DNA damage
response, p53 and Hif1α (Fig. 4d). Thus Tia1 may regulate the
DNA damage response in etoposide treated B cells.
Tia1 controls p53 mRNA translation. Following B-cell activa-
tion in vitro p53 mRNA abundance increases 1.5-fold (Supple-
mentary Fig. 4A, B), although p53 protein is hardly detectable at
any time point (Supplementary Fig. 4C). Total p53 mRNA levels
remained constant after B-cell treatment with etoposide (Fig. 4e
and Supplementary Fig. 4D). By contrast, p53 mRNA association
with ribosomes increased, suggesting that a higher number of p53
transcripts were used for protein synthesis after induction of a
DNA damage response (Fig. 4e). Indeed, distribution analysis of
p53 transcripts in the different polysome fractions showed a
signiﬁcant increase in the number and proportion of transcripts
in heavy polysomes upon B cell treatment with etoposide indi-
cating greater p53 mRNA translation (Fig. 4f, Supplementary
Fig. 4D and Supplementary Data 6). Production of active p53
protein after DNA damage induction was reﬂected by an increase
in total mRNA abundance and polysome association of mRNAs
encoding Gadd45a and Cdkn1a (p21; Supplementary Fig. 4D and
Supplementary Data 6), two previously described p53-dependent
genes33, 34 the expression of which was partially reduced when B
cells were pre-treated with the p53 inhibitor Piﬁthrin-α (Sup-
plementary Fig. 4E, F). In summary, our data suggest that post-
Fig. 1 Stress granules and P-bodies are assembled after B-cell activation. a Quantitation by RT-qPCR of mRNA expression of PBs and SGs components in B
cells after LPS activation. Data from at least two independent experiments are shown as mean + s.e.m. (Mann–Whitney test, ns non-signiﬁcant, * P< 0.05,
**P< 0.01, ***P< 0.001). b Immunoblot analysis of Dcp1a and Tia1 protein abundance in LPS- activated B cells. c Visualization of Dcp1a and Tia1 containing
granules in ex vivo and LPS-activated B cells by confocal microscopy. Nuclei were stained using Dapi. The number of Dcp1a and Tia1- containing granules
per cell is shown in the right panels. Quantitation was performed using Volocity Image software based on ﬂuorescence accumulation within granules. A
minimum of six confocal images from three independent experiments were analyzed. Data shown as mean + s.d. Statistical analysis of the number of
objects in treated B cells compared to untreated B was performed using a Mann–Whitney test. (Scale bar= 10 μm). d Detection and feature distribution
analysis of Tia1 binding to its mRNA targets in the cytoplasm of B cells treated with LPS for 48 h. Top panel, autoradiography showing Tia1:RNA complexes
labelled with 32P-ATP after complete or partial RNA digestion with RNaseI. Red box indicates the RNA:protein complexes puriﬁed for cDNA library
preparation and iCLIP analysis. Bottom panel, distribution analysis of iCLIP cDNA counts mapped to the indicated genomic features (3′UTR, 5′UTR, ORF,
intergenomic, intron and ncRNA). Data from the two Tia1 iCLIP experiments performed using B-cell cytoplasmic extracts are shown. e Venn diagram
showing the number of Tia1 mRNA targets identiﬁed in two iCLIP experiments. Only mRNA targets with at least one signiﬁcantly enriched binding site in
the 3′UTR were considered (transcripts collapsed by gene id, peak enrichment analysis, FDR< 0.05). f Gene ontology (GOrilla and REViGO) analysis of
Tia1 mRNA targets in activated B cells. Genes which expression was detected in our mRNAseq libraries from LPS-activated B cells was used as a
background gene list for GO enrichment analysis. Bubble plot sizes indicate the generality of the GO terms. Larger bubbles relate to general terms whereas
smaller bubbles imply more speciﬁc GO terms
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transcriptional control of p53 mRNA translation by Tia1 might
be is a regulatory mechanism in activated B cells that is respon-
sible for changes in gene expression during the DNA damage
response.
Tia1 binding to p53 3′UTR controls mRNA translation. Tia1
has been implicated in mRNA subcellular location and transla-
tional silencing25, 29, therefore we hypothesized that Tia1 was
responsible for p53 translational control in B lymphocytes. iCLIP
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Fig. 2 DNA damage induces changes in mRNA translation decoupled from total mRNA abundance. a Experimental set up for the study of
etoposide- induced changes in total mRNA abundance (mRNAseq) and mRNA translation (Polyribosome proﬁling followed by 3′end RNA sequencing;
PolyRibo-3′ RNA-seq) in B cells. Libraries from four biological replicates were generated for both mRNAseq and PolyRibo-3′ RNA-seq. Changes in total
cellular mRNA abundance, changes in ribosome-associated mRNAs and changes in polysome distribution after induction of DNA damage were analyzed
using DESeq2 (transcripts collapsed by gene id). b Visualization as MA plots of changes in B-cell transcriptome and B-cell translatome after etoposide
treatment (20 μM, 4 h) (LPS= L, LPS + Etoposide= LE). Top panel, MA plot showing the mean expression of mRNA transcripts in B cells vs. changes in
total mRNA abundance after treatment with etoposide (mRNAseq). Middle panel, MA plot showing the mean abundance of ribosome- associated mRNAs
vs. changes in mRNA translation induced by etoposide (PolyRibo-3′ RNA-seq) (grey—unchanged mRNAs in both datasets, black—mRNAs that change in
cellular mRNA abundance only, red—mRNAs with a translational change only, blue—mRNAs that change at both mRNA abundance and translation).
Bottom panel, Venn-diagram with the number of mRNAs that change in abundance, translation or both. c Venn-diagram showing the number of mRNA
transcripts with signiﬁcant changes in monosome, light and heavy polysome fractions (mRNA fraction distribution analysis). d Proportion of differentially
expressed (DE) mRNAs, differentially ribosome-associated mRNAs or both that show a signiﬁcant change in polysome distribution. mRNAs are grouped
based on signiﬁcant changes in abundance in any of the fractions (fractions 4 to 16) or in monosomes only (fractions 4 to 7), in light polysomes (fractions
8 to 10) or in heavy polysomes (fractions 11 to16). e Proportion of genes with a change in polysome distribution (deﬁned change in any of the fractions,
monosomes, light polysomes and heavy polysomes) that are differentially expressed (DE, change in total mRNA abundance), differentially associated with
ribosomes or show a change in RiboLoad (deﬁned as the proportion of reads in heavy polysomes divided by the total of reads mapped to a given mRNA
transcript; [LPS + Etoposide vs. LPS and 0.75< RiboLoad< 1.25])
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mapping of Tia1:p53 mRNA interactions showed that Tia1 binds
to two U-rich sequences present in the p53 3′UTR called prox-
imal (P) and distal (D) binding sites based on their relative
proximity to p53 stop codon (Fig. 5a and Supplementary Fig. 5A).
To gain mechanistic insight into how Tia1 binding to these
sequences controls mRNA translation we cloned the p53 3′UTR
downstream of a renilla luciferase reporter gene and used a
HEK293 cell system to evaluate translation. Knock down of
endogenous Tia1 increased expression of the renilla luciferase
reporter gene without changes in the abundance of renilla luci-
ferase mRNA (Fig. 5b and Supplementary Fig. 5D). The increase
in luciferase activity was directly related to the extent of mRNA
and protein depletion caused by each of the three different
dsiRNAs used to target Tia1 (Supplementary Fig. 5B, C). No
changes in activity of the luciferase reporter were observed when
Hprt was knocked down (Fig. 5b and Supplementary Fig. 5B, D).
Mutation of the proximal and distal Tia1 binding sites in the p53
5′UTR increased the activity of the reporter gene without changes
in mRNA abundance (Fig. 5c, d and Supplementary Fig. 5E).
Over expression of Tia1 in HEK293 cells reduced luciferase
activity by 40% (Fig. 5d). Importantly, this reduction was abro-
gated by mutation of both proximal and distal Tia1 binding sites
(Fig. 5d). Moreover, over-expression of a mutant Tia1 protein
lacking RNA recognition motifs 1 and 2 was unable to inhibit
expression of the reporter gene (Fig. 5d). Importantly, mRNA
levels of the luciferase reporter remained unchanged in all
conditions tested (Supplementary Fig. 5F) indicating that Tia1
binding to p53 3′UTR controls translation without affecting
mRNA abundance.
Tia1 dissociation allows p53 expression upon DNA damage.
Analysis by confocal microscopy showed that p53 mRNA colo-
calized with Tia1 protein containing SG in B cells (Fig. 6a and
Supplementary Fig. 6A). Tia1 protein was not detected in
monosome and polysome- containing fractions by Western
blotting (Supplementary Fig. 3) suggesting that p53 mRNA
bound by Tia1 and contained within SGs was not quantiﬁed in
our polysome fractionation and sequencing analysis. Induction of
DNA damage with etoposide resulted in p53 mRNA translocation
out of Tia1-containing SG (Fig. 6a and Supplementary Fig. 6A).
Etoposide treatment did not affect SG number and/or size
(Supplementary Figs. 1F, 6B), but promoted dissociation of Tia1
from p53 mRNA (Fig. 6b, Supplementary Fig. 6C, D). This was
not due to depletion of Tia1 following DNA damage as Tia1
protein abundance in B cells was unaffected by etoposide
(Fig. 6c).
DNA damage induced p53 protein expression in primary
mouse B cells (Fig. 6d). To test if the p53 3′UTR could mediate
the induction of p53 upon treatment with etoposide we tested the
response of the 3′UTR reporter in HEK293 cells and found
etoposide signiﬁcantly induced the expression of the reporter
(Fig. 6e) without affecting mRNA abundance when compared to
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Fig. 3 Tia1 mRNA targets are highly responsive to DNA damage. a Proportion of Tia1 mRNA targets compared to non-targeted mRNAs that are
differentially expressed in total mRNA abundance, in ribosome-associated or both after B-cell treatment with etoposide. Tia1 mRNA targets were deﬁned
as those mRNAs in which >50 unique cDNA counts were mapped to the 3′UTR in our Tia1 iCLIP experiments. b Proportion of Tia1 mRNA targets with a
signiﬁcant change in any polysome fraction, in monosomes, light or heavy fractions. Tia1 mRNA targets were divided based on the number of unique cDNA
counts mapped to the 3′UTR (1+, 10+, 25+or 50+). Tia1 untargeted mRNAs were classiﬁed as having none (0) cDNA counts mapped to the 3′UTR. c
Distribution analysis of the fold change in ribosome-associated mRNA abundance of differentially expressed Tia1 mRNA targets compared to
non-targeted mRNAs. Tia1 mRNA targets were sub-divided as in b. d Gene ontology (GOrilla and REViGO) analysis of Tia1 mRNA targets (10+ cDNA
counts mapped to the 3′UTR), which mRNA translation is increased or decreased after B-cell treatment with etoposide (extended in Supplementary
Data 5)
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a control reporter lacking the p53 3′UTR (Supplementary
Fig. 5G). Mutation of the proximal and distal Tia1-binding sites
in the p53 3′UTR increased translation of the reporter gene
further (Fig. 6e) indicating that these sequences enabled
translational regulation of p53 expression upon DNA damage
induction.
Etoposide induces IRES-mediated p53 translation. Changes in
transcription, translation and protein stabilization have been all
linked to the regulation of p53 expression but the relative con-
tribution of each of these processes to p53 induction in mouse B
cells undergoing DNA damage is unknown. Thus, we investigated
further which of these processes contributed to the increased
expression of p53 in B cells following treatment with etoposide.
The inhibition of gene transcription with actinomycin D
increased p53 protein expression to a similar extent as that
induced by etoposide (Fig. 6d and Supplementary Fig. 6E).
Actinomycin D induces DNA damage35, but it did not affect SG
assembly in activated B cells (Supplementary Figs. 1F, 6B). Thus
induction of p53 protein expression in B cells upon etoposide
treatment was independent of the novo p53 mRNA transcription.
Next, we investigated whether proteasome-mediated degradation
controls p53 expression levels in B cells. Inhibition of
proteasome-mediated protein degradation with MG132 or
lactacystin did not increase overall p53 protein abundance in
activated B cells as did etoposide or actinomycin D (Fig. 7a, b).
Interaction of p53 with the E3 ligase mouse double minute 2
homolog (Mdm2) induces p53 protein ubiquitination and
degradation. This interaction is tightly regulated, and destabiliza-
tion of Mdm2 by the ubiquitin-speciﬁc-processing protease 7
(USP7) induces p53 expression and cell cycle arrest36. Inhibition
of the Mdm2-p53 interaction with Nutlin-3 or the p53 Activator
III RITA did not increase p53 protein levels in
LPS-activated B cells (Fig. 7b, c). Etoposide inactivates Mdm2-
mediated regulation of p5337, therefore Mdm2 inhibition did not
enhance p53 expression or activation following DNA damage as
expected. Similar results were obtained when inhibitors of Mdmx
or Usp7 were used, indicating that the Mdm2-p53 axis of
regulation has a minor role in controlling p53 expression in
activated B cells.
De novo translation of pre-existing mRNA was required for
p53 protein synthesis during the DNA damage response.
B-cell treatment with the translation elongation inhibitors
cycloheximide and puromycin blocked p53 protein synthesis
following DNA damage (Fig. 8a, b and Supplementary Fig. 7A).
By contrast, inhibition of CAP-dependent translation initiation
by selective targeting of eIF4E/eIF4G interaction with the
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inhibitor 4EGI-138 did not bock p53 protein synthesis upon
treatment with etoposide or actinomycin D (Fig. 8a, b and
Supplementary Fig. 6A). Expression of Ccnd2, a well-known
target of eIF4E, was reduced by 3-fold indicating effective
inhibition of
CAP-dependent translation by 4EGI-1 (Fig. 8b). Analysis of
ribosome footprints mapped to the p53 mRNA indicated that
ribosomes bind to an internal ribosome entry site (IRES) present
in the 5′UTR of p53 in B cells (Fig. 8c). Notably, analysis of
ribosome footprinting libraries generated from murine bone
marrow dendritic cells, mouse embryonic ﬁbroblasts and mouse
liver cells showed the p53 IRES to be widely used in different cell
types (Supplementary Fig. 5H). Analysis of ribosome footprints
allowed us to identify the IRES nucleotide sequence (CTG)
occupying the ribosome P-site (Fig. 8d and Supplementary
Fig. 5H). To conﬁrm that the p53 IRES was able to recruit
ribosomes in a CAP-independent manner, we generated a
bicistronic luciferase reporter construct in which translation of
a second open reading frame (ORF2), encoding the ﬁreﬂy
luciferase protein, was controlled by the p53 5′UTR. Translation
of ORF1 encoding renilla luciferase was measured as control.
Transfection of HEK293 cells with this bicistronic reporter and
measurement of luciferase activity showed that the p53 IRES
sequence allowed translation of ORF2 (Fig. 8e). Mutation of the
p53 IRES sequence reduced translation of ORF2 by 5-fold
(Fig. 8e) without affecting mRNA abundance (Supplementary
Fig. 5I). DNA damage induction with etoposide increased p53
IRES-dependent translation by 2-fold (Fig. 8f). Mutation of the
p53 IRES prevented this increase in translation caused by
etoposide without altering mRNA abundance (Fig 8f and
Supplementary Fig. 5J), suggesting that the mouse p53 IRES is
necessary for CAP- independent translation, as previously
reported for human p5318, 39. Finally, we measured the renilla/
ﬁreﬂy luciferase ORF ratio by qPCR as in some cases cloning of a
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5′UTR between open reading frames may produce alternative
transcripts due to differential splicing. The renilla/ﬁreﬂy lucifer-
ase ORF ratio was close to 1 in all conditions tested indicating
that our bicistronic reporter constructs were not affected by
alternative splicing (Supplementary Fig. 5I, J). Taken together,
our data suggests that the regulation of translation, rather than
transcription or protein stability, is responsible for p53 protein
expression in B cells during the DNA damage response.
ATM controls Tia1-mRNA dissociation and p53 translation.
Our data indicate that following DNA damage Tia1 is dissociated
from p53 mRNA allowing the exit of p53 mRNA from SGs and
its subsequent translation. This primary regulatory mechanism
activates a p53-mediated genetic program that promotes cell cycle
arrest, DNA damage repair and apoptosis40. The protein kinase
ATM and its downstream targets Chk1 and Chk2 are essential for
signalling control of the DNA damage response41. To gain
mechanistic insight into how Tia1-mediated control of p53
expression is regulated, we selectively inhibited the enzymatic
activity of these enzymes and measured p53 protein induction
following DNA damage.
Inhibition of ATM (with KU55933) or both Chk1 and Chk2
(with AZD7762) prevented p53 induction after B cell treatment
with etoposide (Fig. 9a, b and Supplementary Fig. 7B). Inhibition
of Chk2 alone (with Chk2 inhibitor II) or inhibition of p38
MAPK (with SB203580), a kinase involved in the control of
mRNA stability and translation, resulted in a minor reduction in
p53 protein expression (Fig. 9a and Supplementary Fig. 7B).
Inhibition of ATM or Chk1/2 kinases did not affect p53 mRNA
abundance in B cells treated with etoposide compared to control
cells (Fig. 9c and Supplementary Fig. 7C), but strongly affected
p53 expression and activation as reﬂected by the reduced
phosphorylation of p53 at Serine15 and by the reduced
expression of Gadd45a and Cdkn1a (Fig. 9b). Etoposide-
induced dissociation of Tia1:p53 mRNA complexes that triggers
p53 mRNA translocation out of SGs and translation was reversed
upon ATM kinase inhibition (Fig. 9d and Supplementary Fig. 7G).
This was not due to differential Tia1 and Tial1 protein abundance
after ATM kinase inhibition and DNA damage induction as these
were unchanged in all conditions tested (Fig. 9b). This result led
us to interrogate further the importance of ATM kinase during
the DNA damage response in activated B cells. Global
transcriptome analysis of B cells treated with ATM kinase
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inhibitor KU55933 indicated a partial inhibition of etoposide-
induced gene expression changes, although the transcriptome of
these B cells was more similar to B cells treated with etoposide
than to untreated control cells (Supplementary Fig. 7D, F). This
close similarity was more pronounced when ribosome-associated
mRNA was analyzed (Supplementary Fig. 6E), highlighting that a
single cell-signalling module is not responsible for the complexity
of the DNA damage response.
The ATM kinase-dependent interaction between Tia1 and p53
mRNA led us to investigate whether reduced p53 protein
expression after cell treatment with KU55933 was due to
restoration of Tia1-mediated mRNA translational silencing.
Analysis of p53 mRNA distribution on polysomes showed that
the accumulation of p53 mRNA in heavy polysomes of B cells
treated with etoposide was signiﬁcantly reduced upon inhibition
of ATM kinase (Fig. 9e). Next, we asked whether this could be an
extended cellular mechanism that modulates protein synthesis in
response to DNA damage and interrogated the polysome
distribution of Hif1α and H2-K1, two other targets of Tia1
(Supplementary Fig. 8A, B) that were identiﬁed as having an
increased translation once maintaining their mRNA abundance
(Fig. 4d). Similarly, to p53, Hif1α and H2-K1 mRNA distribution
in heavy polysomes signiﬁcantly increased after B cell treatment
with etoposide (Supplementary Fig. 8C, D). The polysome proﬁle
of Hif1α was restored upon ATM inhibition and, like p53,
resembled the one in control B cells (Supplementary Fig. 8C). The
effect of ATM inhibition in H2-K1 mRNA polysome distribution
was inconclusive although it might suggest that H2-K1 mRNA
shifts to fractions with a lower ribosome occupancy and less
translation (Supplementary Fig. 8D). Taken together, our data
shows that ATM kinase activation during the DNA damage
response modulates Tia1 dissociation from its mRNA targets and
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controls a translational program to produce key proteins that
induce cell cycle arrest and promote DNA damage repair and
apoptosis.
Discussion
Programmed DNA damage is essential for lymphocyte develop-
ment and antigen-mediated terminal differentiation into
antibody-producing cells. Previous studies have focussed their
attention on the characterization of pathways involved in per-
missive DNA repair of the immunoglobulin loci while preventing
chromosomal translocation leading to tumour cell transforma-
tion3, 4. Here we show that post-transcriptional control of mature
mRNA plays an important role in timely mRNA translation of
key modulators of the DNA damage and stress response
including p53 and Hif1α.
DDR is an extensively regulated process linked to cell cycle
progression5, 7 and B-cell differentiation6. Some estimates indi-
cate that B lymphocytes undergoing programmed DNA damage
(CSR and/or SHM) can divide within 5–8 h42, 43. However, gene
expression from DNA transcription to mRNA and translation to
protein occurs stochastically, and for low copy mRNAs signiﬁcant
oscillations and time delays affect the cellular protein content
substantially44, 45. Temporal control of mRNA subcellular loca-
tion in RNA granules and translation has been previously sug-
gested to be an efﬁcient mechanism for timely protein expression
of cell cycle modulators such as Ccnb146. Coordinated control of
RNA regulons is important during cell cycle progression and
DNA damage47. Increased expression of the protein components
and assembly of PBs and SGs upon B-cell activation indicates that
post-transcriptional regulation of mRNA expression is highly
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active in B lymphocytes. We have recently reported that post-
transcriptional mRNA regulation by the RBP Zfp36l1 and
Zfp36l2 is required for cell cycle arrest and effective VDJ
recombination48. Zfp36l1 and Zfp36l2 proteins found within PBs
promote active degradation of their mRNA targets31. Here we
show that binding of the RBP Tia1 to speciﬁc targets, including
p53 mRNA, regulates the residence of these mRNAs within SGs
and their translational silencing. Our study supports the notion
that p53 protein is not expressed in highly proliferative B cells19.
Our data indicate that mRNA translational silencing may be rate
limiting for p53 protein expression in this context.
The global characterization of Tia1:RNA interactions in B-cell
extracts depleted of nuclei has revealed over 3000 genes whose
transcripts have the potential of being translationally silenced
within SGs. Further analysis of the RNA:protein interactions of
other key components of SGs will increase our understanding of
how these transcripts are regulated within these highly dynamic
structures. Tia1 binds within 3′UTRs to U-rich elements similar
to the binding motifs described in introns previously49. DNA
damage induces Tia1 dissociation from its mRNA targets50 and
allows transcript release from SGs, polysome association and
translation of selected regulators of the DDR. iCLIP data inte-
gration with global analysis of mRNA abundance and translation
indicates that Tia1 mRNA targets involved in cell proliferation
and maintenance are decreased upon DNA damage in B cells,
consistent with previously described reduction in CAP-dependent
translation39, 51.
Translation of over 20% of Tia1 mRNA targets is increased
after etoposide treatment. Comparison of changes in mRNA
abundance and polysome association have allowed us to differ-
entiate between genuine changes in translation from those caused
by changes in mRNA abundance. Increased translation of p53,
Hif1α and H2-K1 transcripts is mediated by CAP-independent
translational mechanisms and are independent of “de novo”
transcription. Internal ribosome entry sites (IRES) are present
within p53 and Hif1α transcripts and are used as alternative
translation initiation sites during stress responses39, 52–54. Inhi-
bition of CAP-dependent translation does not prevent p53 pro-
tein synthesis in B cells following DNA damage and our data
show that ribosome recognition of the p53 IRES is functional.
Less is known about the translation of H2-K1 transcripts. How-
ever, a high degree of complexity is expected as different reports
suggest that leucine-tRNA initiation at a CUG- non canonical
start codon encodes for alternative peptides55, 56.
For those Tia1 targets that showed increased mRNA abun-
dance and translation during the genotoxic response we identiﬁed
several genes that are regulated to some extent by p53 and Hif1α,
including Cdkn1a and Gadd45a. These genes can also be post-
transcriptionally regulated. Our iCLIP data reveal that both
Cdkn1a and Gadd45a mRNA are targeted by Tia1 that likely
controls mRNA translation of these regulators of cell growth and
apoptosis during B cell activation. Recent evidence indicates that
Cdkn1a mRNA can be recruited into arsenite-induced stress
granules where its translation is silenced57. Similarly, Tial1
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Fig. 9 ATM kinase inhibition prevents Tia1 dissociation and p53 mRNA translation after DNA damage induction. a Flow cytometry analysis of p53 protein
expression in B cells activated with LPS for 48 h and treated with etoposide (20 μM) for the last 4 h. ATM inhibitor KU55933, Chk1/2 inhibitor AZD7762,
Chk2 inhibitor II and p38 inhibitor SB203580 (all at 10 μM) were added to the cells 1 h before treatment with etoposide. b Immunoblot analysis of
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independent experiments performed is shown. c Total cellular P53 mRNA abundance measured by RT-qPCR. Data are shown as mean + s.e.m. d Tia1
protein: p53 mRNA co-immunoprecipitation in LPS-activated B cells treated with etoposide in the presence of the ATM inhibitor KU55933. An IgG isotype
antibody was used as negative control in these RIP assays. Data are from six independent experiments. 2–3 technical replicates were performed in each
experiment. Mann–Whitney test was performed for statistical analysis and P values are shown. e Polysome proﬁle of p53 from PolyRibo-3′
RNA-seq experiments performed in LPS-activated B cells incubated or not with the KU55933 inhibitor prior treatment with etoposide. Data are shown as
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binding to Gadd45a mRNA silences translation58, 59. Post-
transcriptional derepression of p53, Cdkn1a and Gadd45a mRNA
by genotoxic stress allows synthesis of these proteins, with con-
sequent cell cycle arrest and DDR. Tia1 and Tial1 dissociation
from p53 mRNA in primary B cells is mediated by the ATM
kinase and is less dependent on the MK2/p38 kinase axis that
operates in p53-defective tumor cells59.
ATM-dependent phosphorylation plays a major role in DDR.
Phosphorylation of chromatin associated proteins including
H2AX and 53BP1 marks double strand breaks in the genome,
whereas phosphorylation of p53 mediates transcriptional activa-
tion and cell cycle arrest for DNA repair60–62. ATM activation
controls AID-induced genotoxic stress required for
B-cell differentiation in germinal centers6 and ATM-deﬁciency
results in deﬁcient VDJ-recombination63, 64, reduced CSR10 and
increased chromosomal translocation leading to lymphomagen-
esis65, 66. Our data provide evidence for another layer of control
of the DDR controlled by ATM after B-cell activation. ATM-
dependent dissociation of Tia1 and p53 mRNA release from SG
after genotoxic stress is likely to be linked to p53 IRES folding,
ribosome assembly and p53 mRNA translation67. We have not
studied in detail the role of other protein kinases like ATR and
DNA-PKs, but we anticipate that they can also control ribosome
assembly and mRNA translation. We have gained insight here
using a model that induces extensive DNA damage in primary
cells and believe that this will prompt further studies to under-
stand the importance of mRNA subcellular location and poly-
some assembly during physiological and pathological processes.
Remarkably, our data suggest that post-transcriptional regulation
rather than the proteasome controls p53 protein expression in
activated B cells. This is an attractive and little explored
mechanism that we are now starting to understand.
Methods
Antibodies and oligonucleotides. Information is detailed in Supplementary
Table 1.
Animal Procedures. C57BL/6 mice of 8–12 weeks old were used in this study. All
animal procedures were approved by the Babraham Institute AWEEC and the UK
Home Ofﬁce.
B cell isolation and cell culture. Isolation of B cells from spleen or peripheral
lymph nodes was performed by using the B Cell Isolation Kit from Miltenyi Biotec.
B cells were cultured in RPMI 1640 Medium (Dutch Modiﬁcation) plus 5% FCS,
antibiotics, 2 mM L-glutamine and β-mercaptoethanol (5 µM). Etoposide (Sigma
Aldrich, 20 µM) was added to the B cell cultures after 48 h stimulation with either
LPS (Sigma Aldrich, E.coli 0127:B8, 10 µg ml−1) or with an anti-CD40 antibody
(3/23 clone, 10 µg ml−1) plus recombinant mouse IL-4 (Peprotech, 10 ng ml−1) and
recombinant mouse IL-5 (Sigma Aldrich, 5 ng ml−1). KU55933 (ATM inhibitor,
Tocris, 10 µM), SB203580 (p38 inhibitor, Cell Signalling, 10 µM), Chk2 inhibitor II
(Chk2 inhibitor, Sigma Aldrich, 10 µM), and AZD7762 (Chk1/2 inhibitor, Axon
MedChem, 10 µM) were added, when indicated, 1-h prior treatment with etopo-
side. Actinomycin D (ActD, 5 µg ml −1), cyclohexamide (CHX, 100 μg ml−1),
MG132 (10 μM), Puromycin and SJ172550 were purchased from Sigma Aldrich.
HBX41108 and P005091 were purchased from Tocris. Lactacystin, Piﬁthrin-α,
Nutlin-3, p53 Activator III RITA and 4EGI-1 were puchased from Calbiochem.
Flow cytometry. Intracellular staining of p53 was performed following indications
from the manufacturer (BD Biosciences). Cytoﬁx/Cytoperm and Fixation/Per-
meabilization solutions (BD Biosciences) were used for cell ﬁxation and permea-
bilization as indicated. Data was acquired using a BD LSR II cytometer and
analyzed using FlowJo X (TreeStar).
RNA FISH and confocal microscopy. For confocal microscopy, B cells were
attached to coverslips that were treated with Poly-L-Lysine (Sigma Aldrich) for at
least 1 h. at 37 °C. Ex vivo and activated B cells were cultured and treated as
previously described. Fifteen to 30 min prior cell recovery, B cells (2–5 × 105) were
transferred to 24-well dishes containing the Poly-L-Lysine- coated coverslips. Cell
adhesion was conﬁrmed under the microscope prior washing unattached cells off
with PBS (at 37 °C). Ice-cold methanol was added onto coverslips for B-cell ﬁxation
and permeabilization at −20 °C for 5 min. After drying, cells were ﬁxed again with
4% paraformaldehyde in PBS for 15 min at RT. After extensive washing with
washing buffer (PBS plus 0.3% Triton X-100), cells were blocked for 15 min using
1% BSA in washing buffer prior incubation with speciﬁc antibodies against Tia1,
Dcp1a and eIF3η (see Supplementary Table 1 for more details). After washing,
secondary antibodies coupled to Alexa Fluor 488, Alexa Fluor 555 or Alexa Fluor
647 (Life Technologies) were added. After 1-h incubation, samples were incubated
with Dapi for 10 min and washed with PBS (three times), with H2O (once) and
mounted on microscope slides using Prolong (Life Technologies).
RNA FISH procedure was adapted from Widgerde et al.68 Brieﬂy, a 991
nucleotide- long sequence of the P53 mRNA coding sequence was used as template
for generation of digoxigenin-labeled cDNA probes. Template sequence was
ampliﬁed using speciﬁc B-cell mRNA, speciﬁc p53 PCR primers (forward—
TGCTCACCCTGGCTAAAGTT; reverse: TCTTCTGTACGGCGGTCTCT) and
Pfu Ultra II Fusion HS polymerase (Agilent). Then, it was cloned into a pCR2.1
TOPO® TA cloning vector following manufacturer indications (Life Technologies).
Cloning orientation of P53 template sequence (5′ to 3′) was from the T7 promoter
sequence to the M13 reverse priming site. Five microgram of linearized vector after
BamHI enzymatic digestion was used as template for in vitro transcription using
MAXIscript kit (Ambion) and T7 RNA polymerase (Promega). After DNAse I
treatment, RNA was extracted by phenol/chlorophorm (pH 4.5) extraction
followed by ethanol precipitation using ammonium acetate. Reverse transcription
of RNA probe to generate antisense cDNA probes was performed using a
Superscript III retro-transcriptase (Life Technologies) and digoxigenin (DIG)-11-
2’-deoxy-uridine-5′-triphosphate (alkali-stable from Roche) for probe labelling.
Treatment with RNAse H (Life Technologies) was performed before p53 cDNA
probes puriﬁcation with a Qiaquick Nucleotide Removal Kit (Qiagen). For RNA
FISH, B cells were ﬁxed and permeabilized with methanol followed further ﬁxation
with 4% paraformaldehyde as described before. After extensive washing with
washing solution (0.1% Tween 20 in PBS), coverslips were treated with 70%
ethanol for 5 min at 22 °C prior air drying. Samples were re-hydrated and
incubated in blocking solution (0.1% Tween 20, 5% BSA fraction V or 5%
non-reactive donkey serum in PBS) for 15 min. RNase inhibitors or Ribosyl
Vanadyl Complex (10 mM, New England Biolabs) were added to all washing and
blocking solutions. Then, samples were incubated with an anti-Tia1 primary
antibody (Supplementary Table 1) for 2 h at room temperature. After washing,
samples were re-ﬁxed with 4% paraformaldehyde in PBS for 10 min. Samples were
washed and quenched for 20 min with 0.1 M Glycine in washing solution. Then,
they were incubated twice with 50% formamide/ 2× SSC (5 min each time) prior
incubation with a p53 cDNA probe mix (100 μg ml−1 DIG-labelled oligonucleotide
probe, 50% formamide/2× SSC, 6% PEG, 0.2 mgml−1 BSA fraction V, 0.1 mg ml−1
E. Coli RNase-free tRNA) that was previously denaturalized at 65 °C. Samples were
incubated with the P53 cDNA probe mix over night at 37 °C in a humidiﬁed
chamber. Then, they were sequentially washed with 50% formamide/ 2× SSC (twice
for 10 min at 37 °C), with 50% formamide/ 1× SSC (twice for 15 min at 37 °C), with
1× SSC (once for 15 min at 22 °C), with 0.5× SSC (once for 15 min at 22 °C), with
washing buffer (twice for 5 min at 22 °C) and blocking buffer (once for 15 min at
22 °C). P53 cDNA probes were detected with a sheep anti-DIG antibody coupled to
AlexaFluor 555 (Molecular probes). Tia1 antibody was detected using a donkey
anti-goat secondary antibody coupled to AlexaFluor 647. After 1 h incubation,
samples were washed and mounted in microscope slides as indicated above.
All images were captured with an Olympus FV1000 System and processed using
FV10-ASW 2.0 software. In all experiments, B cells isolated from 2–3 mice were
treated and stained in parallel in each of the, at least, two independent experiments
performed. Images were captured using 60 × objective lens and ×4 digital
magniﬁcation in order to analyze several cells per microscopy ﬁeld. Images from at
least three different microscopy ﬁelds were analyzed per replicate. The number of
Tia1 and Dcp1a objects in each microscopy ﬁeld was calculated based on
ﬂorescence intensity signal using Volocity software and was divided by the number
of cells in each ﬁeld. Data are shown as mean + s.d. (n> 6 for all conditions tested).
Digital magniﬁcation and 3D plot analysis of the ﬂuorescence signal was performed
with Image J software to visualize Tia1- and Dcp1a- containing RNA granules.
Pearson R correlation of ﬂuorescent signal colocalization was calculated with
ImageJ.
Plasmid constructs. The psiCkeck2- p53 3′UTR plasmid was generated by PCR
ampliﬁcation of the mouse Trp53 3′UTR (445 bp) using B cell mRNA as cDNA
template, Pfu Ultra II Fusion HS polymerase (Agilent) and speciﬁc primers
(Supplementary Table 1), followed by cloning into a psiCkeck2 plasmid vector
(Promega). XhoI and NotI restriction enzyme sites were added for directional
cloning downstream the Renilla luciferase ORF. Mutagenesis of the proximal (P)
(closest to the Trp53 stop codon) and/or the distal (D) Tia1 binding sites (closest to
the Trp53 PolyA signal) was performed using Gibson assembly to generate the
following plasmid: psiCkeck2- p53 3′UTR P-mutant (P-Mut), psiCkeck2- p53
3′UTR D-mutant (D-Mut) and psiCkeck2- p53 3′UTR P-D-mutant (P-D-Mut).
The bicistronic Trp53 IRES vector was generated by substituting the
polyadenylation site of the renilla luciferase and the Herpes simplex virus (HSV)
thymidine kinase promoter, present upstream the ﬁreﬂy luciferase CDS in the
psiCheck2 vector, with the mouse Trp53 5′UTR (NM_011640.3). Trp53 ribosome
entry site was substituted by a SalI restriction enzyme site to generate the Trp53
IRES mutant vector.
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Mouse Tia1 and a mutant Tia1 lacking the RNA-recognition motifs 1 and 2
were cloned into the MIGR1 plasmid vector after PCR ampliﬁcation using speciﬁc
primers (Supplementary Table 1). Restriction enzyme sites for BglII and EcoRI
were added and used for directional cloning into the MIGRI plasmid vector.
Luciferase reporter assays. HEK293T (293T ATCC CRL-3216) cells, cultured in
DMEM supplemented with 10% FCS, 2 mM L-glutamine and 1% Penicillin/
Streptomycin, were transfected with the indicated plasmid constructs using
Lipofectamine 2000 (ThermoFisher). Renilla and ﬁreﬂy luciferase expression was
measured after 24 h with a Dual-Luciferase Reporter Assay System (Promega).
Each independent experiment was performed in duplicates or triplicates. Data are
shown as relative luciferase units. In those experiments assessing the role of p53
3′UTR in mRNA translation, relative luciferase units are calculated by dividing the
number of renilla luciferase units by the number of ﬁreﬂy luciferase units (to
control for changes due to different transfection efﬁciencies). To account for
extrinsic changes in the Dual-Luciferase® Reporter Assay System due to cell
treatment with etoposide, Tia1 over-expression or Tia1 knockdown, relative luci-
ferase units were further normalized by the relative changes in renilla luciferase
translation compared to ﬁreﬂy luciferase translation in cells transfected with a
control psiCkeck2 empty vector. Trp53 IRES dependent translation was quantiﬁed
by measuring ﬁreﬂy luciferase translation relative to control renilla luciferase
translation. At least three independent experiments were performed and pulled
data is shown as mean + s.d. Statistical analysis was performed using the unpaired
Student’s t-test.
Dicer-substrate short interfering RNAs and gene knock down. TriFECTa
dsiRNA duplex kits containing three different Dicer-substrate short interfering
RNAs (DsiRNAs) against Tia1 or Hprt were purchased from Integrated DNA
Technologies (IDT). Hprt dsiRNA and scramble dsiRNA provided with the kit
were used as experimental negative controls. DsiRNAs were transfected into
HEK293 cells by using Lipofectamine RNAiMAX transfection reagent (Thermo-
Fisher). After 48 h, plasmid and dsiRNA were co-transfected with using Lipo-
fectamine 2000 (ThermoFisher). Gene knock down was evaluated 24-h after using
qPCR and ﬂow cytometry. Renilla and ﬁreﬂy luciferase expression was measured
with a Dual-Luciferase Reporter Assay System (Promega).
Polysome fractionation. For polysome fractionation, B cells were incubated with
cyclohexamide (CHX, Sigma Aldrich, 100 μg ml−1) for 3 min at 37 °C prior col-
lection. After washing the cells with ice-cold PBS containing CHX (100 μg ml−1),
cell pellets were either stored at −80 °C or resuspended in polysome buffer (300
mM NaCl, 15 mM MgCl2, 15 mM Tris-HCl; pH 7.5, 100 μg ml−1 cycloheximide
CHX, 100 U RnaseOUT from Life Technologies) containing 1% Triton X-100.
After incubation on ice for 10–15 s, cells were spun at 17,000 × g at 4 °C. Cyto-
plasmic cell supernatant was placed at the top of a 50–10% sucrose gradient pre-
pared previously in 17 ml- Beckman tubes (by underlying, from the bottom to the
top, 3 ml of 10, 20, 30, 40 and 50% sucrose solutions made up in polysome buffer).
Then, samples were centrifuged at 250,000 × g for 2hr at 4 ˚C (acceleration 7,
deceleration 7) using a pre-cooled SW41Ti. Samples were kept at 4 °C at all times.
One millilitre fractions were automatically collected using gradient fractionator
after injecting a 65% sucrose solution (made up in polysome buffer containing
Bromophenol blue as a tracer dye) to the bottom of the tube. Polysome fractions
were mixed with 3 ml of 7.7 M guanidine HCl and 4 ml of 100% ethanol, and
incubated overnight at −20 °C.
RNA extraction and RT-qPCR. Ethanol precipitation procedure was follow for
mRNA precipitation. mRNA was used for either 3′ RNA-seq library preparation
(described below) or it was converted into cDNA to perform RT-qPCR analysis as
follows69: Brieﬂy, RNA retro-transcription (RT) was performed using SuperScript
II (Life Technologies) and qPCR assays were performed using Platinum Quanti-
tative PCR SuperMix-UDG or SYBR Green PCR Master Mix (Life Technologies).
Total RNA extraction was performed using TriZol (Life Technologies) and con-
verted into cDNA similarly. Primers and Taqman probes used are described in
Supplementary Table 1. Quantiﬁcation of cell mRNAs was calculated by the ΔΔCT
(comparative threshold cycle) method, following manufacturer’s instructions. 18S
rRNA and β2m were tested to normalize mRNA abundance. Data are shown as
relative quantiﬁcation to the mRNA levels of either ex-vivo or LPS- stimulated B
cells as indicated in each ﬁgure legend. Quantiﬁcation of mRNA levels in each
polysome fraction is shown as arbitrary units (a.u.).
SDS-page and immunoblotting. Protein from each polysome fraction was pre-
cipitated using trichloroacetic acid (TCA). Brieﬂy, 1 volume of 20% TCA was
added to each fraction. After incubation overnight at 4 °C, samples were spinned
down at 17,000 × g. Pellet was washed twice with 0.5 ml of ice-cold acetone. After
drying the pellet, protein was resuspended in sample reducing buffer (2×) con-
taining 2-mercaptoethanol. 10% of the total was loaded in 10−12% polyacrylamide-
SDS gels.
Total B cell protein extracts were prepared using RIPA buffer (50 mM Tris-HCl,
pH 7.4, 150 mM NaCl, 1% NP-40, 0.1% SDS and 0.5% sodium deoxycholate)
containing protease and phosphatase inhibitors (Protease inhibitor cocktail 3,
Sigma Aldrich). After 15 min at 4 °C, samples were centrifuged (17,000 × g, 5 min)
to isolate protein containing supernatants. Protein concentration was measured
using a BCA protein assay (Pierce). 10% polyacrylamide-SDS gels were loaded with
20 μg. of protein lysate for electrophoresis. Proteins were then transferred to
nitrocellulose membranes and immunoblotted with speciﬁc primary antibodies
against p53, p53-Ser15, Cdkn1a p21, Gadd45a, Tia1, Tial1, eIF3η, G3BP1, PABP1,
Dcp1a and β-actin (Antibody dilution 1:1000; see Supplementary Table 1). Speciﬁc
HRP-conjugated secondary antibodies followed by enhanced chemiluminescence
(Amersham Pharmacia Biotech) were used for detection. Uncropped immunoblot
scans with molecular size markers are provided in the Supplementary Data.
Individual-cross-linking and immunoprecipitation (iCLIP). iCLIP experiments
were performed with minor modiﬁcations as previously described30, 70. Brieﬂy,
primary splenic B cells were activated with LPS for 48 h prior UV- light
crosslinking (245 nm light, 150 mJ cm−2 using a Stratalinker 2400) of protein :
RNA interactions. Cytoplasmic extracts were obtained after incubation with
cytoplasmic extract lysis buffer (10 mM HEPES; pH 7.6, 10 mM KCl, 0.1 mM
EDTA, 0.1 mM EGTA and protease inhibitors) as described above, and treated for
3 min at 37 °C with a high concentration (12 Uml−1) or a low concentration of
RNase I (0.167 Uml−1). Tia1:RNA complexes were immunoprecipitated using 2 μg
an anti-Tia1-speciﬁc antibody (Supplementary Table 1) coupled to protein G
Dynabeads. An isotype IgG antibody was used as negative control and speciﬁc Tia1
immunoprecipitation was checked by western blot. After immunoprecipitation,
beads were washed twice with high-salt buffer (50 mM Tris-HCl, pH 7.4, 1 M NaCl,
1 mM EDTA, 1% NP-40, 0.1% SDS and 0.5% sodium deoxycholate) and twice with
PNK washing buffer (20 mM Tris-HCl, pH 7.4, 10 mM MgCl2 and 0.2% Tween-
20). One tenth of each sample was labelled with 32P-ATP using PNK. The rest was
ligated to an RNA linker after RNA 3′ dephosphorylation. RNA–protein complexes
were separated by SDS-PAGE and were transferred to nitrocellulose membranes.
Tia1-RNA complexes with a molecular size above 55 KD were isolated after
visualization by autoradiography. RNA extraction from the nitrocellulose was
performed with proteinase K in 200 μl of PK buffer (100 mM Tris-HCl, pH 7.5, 50
mM NaCl and 10 mM EDTA) for 10 min at 37 °C. After that, additional 200 μl of
PK buffer containing urea (7 M) were added to each sample that was further
incubated for 20 min at 37 °C. RNA was isolated by phenol-chloroform extraction
and ethanol precipitation, and retrotranscribed into cDNA using RCLIP primers
(Supplementary Table 1) and SuperScript III. cDNA puriﬁcation was performed
using 6% TBE-urea gels and was followed by cDNA circularization and ampliﬁ-
cation by PCR using Solexa P5/P3 primers. cDNA libraries were analyzed prior
Illumina (GaIIX) sequencing. RCLIP primers include a seven-base-long ‘barcode’
at the 5′ end (three known bases plus four unknown nucleotides) for sample
multiplexing and PCR duplicate read identiﬁcation. Two known bases (AT, 3′
barcode) were added to the 3′end of each RNA molecule by the RCLIP primers.
RNA immunoprecipitation (RIP). Validation of Tia1 and Tial1 interaction with
selected mRNA targets was performed by RIP as follows69: Brieﬂy, RIP assays were
performed with cytoplasmic cell extracts were obtained using cytoplasmic cell lysis
buffer (10 mM TrisHCl; pH 7.4, 10 mM NaCl, 2.5 mM MgCl2, 40 µg ml−1 digitonin
from Sigma Aldrich) containing protease inhibitors (p8340, Sigma Aldrich) and
RNase inhibitors (40 Uml−1 of RNase Out, Life Technologies). After incubation on
ice for 15 min, 10 µl of 10% NP-40 were added. Samples were then vortex for 10 s
and centrifuged at 900 × g at 4 °C for 20 min. Supernatant was collected as the
cytoplasmic fraction. Protein A/G magnetic beads (Pierce, ThermoFisher Scientiﬁc)
were coupled with 2 μg of antibody against Tia1 or Tial1 or an isotype control IgG
antibody (Supplementary Table 1). After 1-h incubation at room temperature,
beads were washed with NET-2 buffer (50 mM Tris-HCl pH 7.5, 500 mM NaCl,
0.05% NP-40 and 1 mM MgCl2). Two hundred ﬁfty microgram of cytoplasmic
protein extracts were added to the antibody-coupled beads for immunoprecipita-
tion (overnight at 4 °C in rotation). Then, beads were washed (5×) with NET-2
buffer and proteins were digested with proteinase K (0.5 mg ml−1, Roche) dissolved
in NET-2 buffer containing 0.1% SDS. After 15 min at 55 °C, RNA was extracted by
adding an equal volume of phenol: chloroform: isoamyl alcohol (25:24:1, Sigma,
P3803). After mixing, centrifugation and isolation of the hydrophilic sample phase,
RNA was precipitated using 0.1 volumes of 3M NaOAc, 0.3 volumes of 1 mM
EDTA and 2.5 volumes of 100% ethanol. RNA pellets were washed twice with 70%
ethanol prior drying and re-suspension in water. Reverse transcription into cDNA
and qPCR assays were performed as described above. Data from RNA immuno-
precipitation assays are shown as fold enrichment relative to LPS- only treated B
cell samples. In all experiments, samples from two or three biological replicates
were processed in parallel to determine biological variability. Data are shown as
Mean + s.d.
Library preparation and high throughput sequencing. mRNAseq libraries were
generated with a TruSeq Stranded mRNA Sample Prep Kit (Illumina). mRNAseq
and iCLIP cDNA libraries were sequenced with a HiSeq2000 Illumina system
(mRNAseq—100 bases, single end; iCLIP—50 bases, single end). mRNAseq data
from naïve and LPS-activated B cells were obtained from publically available data
sets (GSE62129). cDNA libraries for PolyRibo-3′ RNA-sequencing was performed
using identical concentrations from each of the RNA sample fractions collected
after polysome fractionation that was performed as indicated above. Between 62.5
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and 625 ng of RNA was retro-transcribed using one speciﬁc RmRNAt primer with
a unique 10-bases barcode that allows library multiplexing (41 libraries were
multiplexed in each sequencing lane) and PCR deduplication. Of the 10-bases
barcodes, 5 nucleotides were known (for library multiplexing) and 5 unknown (for
PCR deduplication) (Supplementary Table 1). After cDNA isolation and pur-
iﬁcation using Qiagen PCR puriﬁcation kit, input material was ampliﬁed using the
MessageAmp II aRNA Ampliﬁcation kit. Brieﬂy, a second DNA strand was gen-
erated. Double strand DNA was puriﬁed using cDNA Filter Cartridges and in vitro
transcription was then performed using T7 RNA polymerase. After DNA degra-
dation using DNAse I, ampliﬁed in-vitro transcribed RNA was puriﬁed using the
aRNA ﬁlter cartridges provided. Then a second retro-transcription was performed
using the 2RT primer. After RNA digestion with RNAse A, cDNA of a size between
110–150 bases was puriﬁed using TBE-Urea gels and used as template for PCR
library ampliﬁcation using P5/P3 Solexa primers. cDNA libraries were then
sequenced using a HiSeq1000 Illumina system. Paired sequencing was performed
(10 cycles from the 5′ end to read unique barcode and 60 cycles from the 3′end).
Ribosome footprinting libraries have been described previously (GSE62148)70.
Bioinformatics and statistics. FastQC was used for quality analysis of sequencing
data. Data analysis was done in the iCount pipeline30. Read mapping and peak call
analysis of Tia1 iCLIP data30, 70 was done as follows: Brieﬂy, sample demultiplexing
was performed based on the three known bases present at the 5′end of each read.
The four unknown bases of the 5′ ‘barcode’ were used for removal of PCR duplicate
reads. The length of unique reads was deﬁned by a two bases (AT)- long 3′ barcode.
Reads were then trimmed to remove adaptor and barcode sequences before
mapping to the genome with Bowtie. Mouse genome assembly GRCm37 (NCBI;
UCSC mm9 annotation) was used originally. Data were lifted over to GRCm38
(NCBI) assembly if required by using Galaxy. Nucleotide position −1 (relative to
the ﬁrst base annotated, set as position 0) of each read deﬁnes Tia1-
crosslink–binding site. The number of unique cDNA counts associated to a
Tia1-crosslink site is deﬁned by both read length and the uniqueness of the 5′
‘barcode’ sequence. Peak enrichment analysis was performed in iCount by
genome-wide analysis of 30 base windows (15 nts. upstream and downstream from
each mapped Tia1 crosslink site), allowing 100 permutations and multiple-
hypothesis testing to correct for multiple comparisons. All Tia1- crosslink sites
with a false-discovery rate (FDR) higher than 0.05 were not further considered.
Tia1:RNA binding sites were associated to a particular genomic feature (5′UTR,
3′UTR, ORF, introns, ncRNA or intergenic—mm9 annotation-) and visualized in
the UCSC genome viewer. Gene ontology (GO) analysis was performed using
GOrilla and REViGO. GO terms related to biological processes (BP) were used.
mRNAseq data were mapped with TopHat2 and counted using HTSeq
(Mus_musculus.GRCm38.78.gtf). Differential expression analysis was performed
with DESeq2, that adjusted the data to a negative binomial distribution after
correction by library size factor. Benjamini-Hochberg multiple test correction of
the P values was performed to calculate adjusted P values (Padj< 0.01 was used as
threshold of signiﬁcance).
Data from PolyRibo-3′ RNA-sequencing was mapped to GRCm38/mm10
genome (gene and transcript annotation Ensembl 66.8) after demultiplexing and
PCR deduplication based on 5′ end barcodes annotated in the 10 bp-ﬁrst read of
the Illumina run (see Supplementary Table 1 from RmRNAt primer sequence).
Location and length analysis of the longest consecutive A tract in raw reads from
the 60bp-second read of the Illumina run (deposited in GEO, see accession
numbers below) was done ﬁrst. Removal of the A-tract from reads was performed
according to the following rules (tail length, A tract length, allowed mismatches in
tract): (20, 17, 2), (19, 16, 2), (18, 15, 2), (17, 14, 2), (16, 13, 1), (15, 12, 1), (14, 11,
1), (13, 10, 1), (12, 10, 1), (11, 9, 1), (10, 8, 1), (9, 8, 1), (8, 7, 0), (7, 6, 0), (6, 5, 0),
(5, 3, 0), (4, 3, 0). Reads containing internal A-tracts were cut according to the rule
(minimal A tract length, allowed mismatches in tract): (17, 2). Finally, any
remaining A at the end of the read was removed prior alignment to the reference
genome and counting. Raw counts were used to generate a sample data matrix for
DESeq2 to identiﬁed changes in the polysome fraction proﬁle of each gene. First, a
generalized linear model (GLM; read.counts ~ condition + polysome.fraction +
condition:polysome.fraction) was estimated for polysome data and, second, the
likelihood ratio test was performed between the original and a reduced (read.counts
~ polysome.fraction) GLMs. Then, we used a post-hoc pairwise t-test to ﬁnd genes
with the most signiﬁcant fraction change between conditions in monosome, light
and heavy fractions. The signiﬁcance P-value threshold used in the pairwise t-test
was 0.01. Although 3′RNA sequencing allows identiﬁcation of alternative polyA
site usage, it does not enable to identify and quantify alternatively spliced mRNA
transcripts. Therefore, counts mapped to an Ensembl-deﬁned gene unit were
summed up and analyzed. The same approach was taken for quantifying mRNA
abundance by mRNAseq.
mRNA and PolyRibo-3′ RNA-sequencing data from 4 biological replicates were
collected to estimate variation and ensure reproducibility. Analysis of variance
(ANOVA) followed by Bonferroni’s correction, unpaired Student’s t-tests or
Mann-Whitney tests were performed for statistical analysis of non-sequencing data
as indicated in each ﬁgure legend.
Data availability. The data sets generated during and/or analyzed during the
current study are available in Gene Expression Omnibus. Accession codes are:
GSE62148 and GSE93576 (subseries GSE93573, GSE93574 and GSE93575). All
other data are available upon request.
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